TheEdgeResearch
Home / Stocks / PNGAF

The Precision Peptide Company Inc (PNGAF)

OTC Consumer Cyclical Restaurants
$0.32 ▲ +6.97%
Market Cap
$4.8M
Sector
Consumer Cyclical
Industry
Restaurants
Beta
0.18
52-Wk Range
0.0077-0.5
CEO
Pratapvir Sandhu
Country
CA
Currency
USD

The Precision Peptide Company Inc operates in the Restaurants industry of the Consumer Cyclical sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.32, up 6.97% on the session, giving a market capitalisation of $4.8M. On trailing twelve-month figures it carries a trailing P/E of -2.84, a net margin of -8804.2%. Its beta of 0.18 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-2.84
Price / Sales
432.22
Price / Book
13.92
EV / EBITDA
-10.29
Gross margin
-48.8%
Operating margin
-4131.0%
Net margin
-8804.2%
Return on equity
—
Debt / equity
0.00
Current ratio
3.32
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2022-08-25
Headquarters
Vancouver, BC, CA
About The Precision Peptide Company Inc

The Precision Peptide Company Inc. operates as a wellness company. It manufactures and distributes peptide formulations and nutritional supplements, focusing on non-invasive delivery systems. The company's products are aimed at health optimization, including areas like stress management, gut health, longevity, and skin repair, and are sold directly to consumers.

Comparable companies

The Precision Peptide Company Inc is most often compared with the following Consumer Cyclical names:

AIXNARRTCEUMFCLGOFEWLUFLWBFGLUCPSYCFRELVTOFB
More research on PNGAF
PNGAF technical analysis PNGAF TheEdge Score Compare against peers
Open full interactive analysis & DCF →